Intrathecal CGRP8-37 results in a bilateral increase in hindpaw withdrawal latency in rats with a unilateral thermal injury

Neuropeptides

Volumn 31, Issue 6, 1997, Pages 601-607

  Lofgren O ^a,b   Yu, L C ^a,c   Theodorsson, E ^b   Hansson, P ^b   Lundeberg, T ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Dept of Rehabilitation Medicine   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR;

ARTICLE; CEREBROSPINAL FLUID EXAMINATION; IMMUNOREACTIVITY; NOCICEPTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SPINAL CORD; THERMAL INJURY; WITHDRAWAL REFLEX;

EID: 0031443438     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90006-8     Document Type: Article

References (22)

1. Hökfelt T, Arvidsson U, Ceccatelli S et al. Calcitonin gene-related peptide in the brain, spinal cord and some peripheral systems. Ann New York Acad Sci 1992; 657: 119-133.
2. Biella G, Panara C, Pecile A, Satgiu ML. Facilatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P and noxious stimuli in rat spinal dorsal horn neurones: an iontophoretic study in vivo. Brain Res 1991; 559: 352-356.
3. Kawamura M, Kuraishi Y, Minami M, Satoh M. Antinociceptive effect of intrathecally administered antiserum against calcitonin gene-related peptide on thermal and mechanical noxious stimuli in experimental hyperalgesic rats. Brain Res 1989; 497: 199-203.
4. Kuraishi Y, Nanayama T, Ohno H, Minami M, Satoh M. Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptide. Neurosci Lett 1988; 92: 325-329.
5. Satoh M, Kuraishi Y, Kawamura M. Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia: comparison with carrageenan-induced hyperalgesia. Pain 1992; 49: 273-278.
6. Cridland RA, Henry JL. Intrathecal administration of CGRP in the rat attenuates a facilitation of the tail flick reflex induced by either substance P or noxious cutaneous stimulation. Neurosci Lett 1989; 102: 241-246.
7. Donner J, Stein C. Evidence for an increase in the release of CGRP from sensory nerves during inflammation. Ann New York Acad Sci 1992; 657: 505-506.
8. Bileviciute I, Lundeberg T, Ekblom A, Theodorsson E. Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peoptide- and neuropeptide Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci Lett 1993; 153: 37-40.
9. Bileviciute I, Lundeberg T, Ekblom A, Theodorsson E. Substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity (-LI) in rat knee joint synovial fluid during acute monoarthritis is not correlated with concentrations of neuropeptides-LI in cerebrospinal fluid and plasma. Neurosci Lett 1994; 167: 145-148.
10. Draisci G, Kajander KC, Dubner R, Bennett GJ, Iadarola MJ. Upregulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res 1991; 560: 186-192.
11. 8-37 increases the latency to withdrawal responses in rats. Brain Res 1994; 653: 223-230.
12. Theodorsson E, Stenfors C, Mathe AA. Effect of repeated electroconvulsive intestinal polypeptide, neuropeptide Y and galanin in rat brain. J Neurosci Res 1990; 24: 445-450.
13. Hanesch U, Pfrommer U, Grupp BD, Heppelmann B, Schaible H -G. The proportion of CGRP-immunoreactive and SP-mRNA containing dorsal root ganglion cells is increased by a unilateral inflammation of the ankle joint of the rat. Regulatory Peptides 1993; 46: 202-203.
14. Mayer EA, Raybould H, Koelbel C. Neuropeptides, inflammation, and motility. Digestive Diseases and Sciences 1988; 33: 71S-77S.
15. 8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmac Exp Ther 1990; 254: 123-128.
16. Poyner DR. Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmac Ther 1992; 56: 23-51.
17. Oku R, Satoh M, Fujii N, Otaka A, Yajima H, Takagi H. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res 1987; 403: 350-354.
18. Yaksh TL, Malmberg AB. Central pharmacology of nociceptive transmission. In: Wall PD, Melzack R, Textbook of pain. Edinburgh: Churchill Livingstone, 3rd edition, 1994: pp. 165-190.
19. Pohl M, Mauborgne A, Bourgoin S, Benoliel JJ, Hamon M, Cesselin F. Neonatal capsaicin treatment abolishes the modulations by opioids of substance P release from rat spinal cord slices. Neurosci Lett. 1989; 96: 102-107.
20. Collin E, Frechilla D, Pohl M et al. Opioid controls the releases of calcitonin gene-related peptide-like material from the rat spinal cord in vivo. Brain Res 1993; 609: 211-222.
21. Mcneill DL, Chung Carlton SM, Coggeshall RE. Calcitonin gene-related peptide immunostained axons provide evidence for fine primary afferent fibers in the dorsal and dorsolateral funiculi of the rat spinal cord. J Comp Neurol 1988; 272: 303-308.
22. Takahashi S, Traub R, Ruda MA. Ultrastructural demonstration of synaptic connections between calcitonin gene-related peptide immunoreactive axons and dynorphin A(1-8) immunoreactive dorsal horn neurons in a rat model of peripheral inflammation and hyperalgesia. Peptides 1990; 11: 1233-1237.